Last edition
News about "Scopolamine Transdermal System "
Zydus Gets Final Approval from USFDA for Scopolamine Transdermal System
Scopolamine Transdermal System is indicated to prevent nausea and vomiting after anaesthesia, narcotic pain medicines, and surgery.
Scopolamine Transdermal System | 31/08/2024 | By Aishwarya | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members